Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
111.41
-2.27 (-2.00%)
At close: Aug 21, 2026
NSE:GAUDIUMIVF Revenue
Gaudium IVF and Women Health had revenue of 205.00M INR in the quarter ending June 30, 2026, a decrease of -23.86%. This brings the company's revenue in the last twelve months to 1.07B, up 51.44% year-over-year. In the fiscal year ending March 31, 2026, Gaudium IVF and Women Health had annual revenue of 1.04B with 47.56% growth.
Revenue (ttm)
1.07B
Revenue Growth
+51.44%
P/S Ratio
7.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.11B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.04B | 336.33M | 47.56% |
| Mar 31, 2025 | 707.24M | 228.34M | 47.68% |
| Mar 31, 2024 | 478.90M | 36.35M | 8.21% |
| Mar 31, 2023 | 442.55M | 77.36M | 21.18% |
| Mar 31, 2022 | 365.20M | 303.45M | 491.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sree Rayalaseema Hi-Strength Hypo | 6.98B |
| Swaraj Suiting | 6.83B |
| TVS Electronics | 4.65B |
| Borana Weaves | 4.08B |
| Prostarm Info Systems | 4.07B |
| Excelsoft Technologies | 2.97B |
| A B Infrabuild | 2.72B |
| Panache Digilife | 2.64B |